Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
International Journal of Cancer|July 18, 2009
Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and AktDong Bai, Lynn Ueno, Peter K VogtProceedings of the National Academy of Sciences of the United States of America|September 3, 2004
Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteinsMasahiro Aoki, Hao Jiang, Peter K VogtOncogene|September 13, 2003
MafA has strong cell transforming ability but is a weak transactivatorMakoto Nishizawa, Kohsuke Kataoka, Peter K VogtOncotarget|July 17, 2010
Smooth muscle α-actin is a direct target of PLZF: effects on the cytoskeleton and on susceptibility to oncogenic transformationJin Shi, Minghao Sun, Peter K VogtCell Cycle (Georgetown, Tex.)|May 27, 2005
Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteinsPeter K Vogt, Hao Jiang, Masahiro AokiCurrent Topics in Microbiology and Immunology|June 16, 2010
PI3K: from the bench to the clinic and backBart Vanhaesebroeck, Peter K Vogt, Christian RommelProceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Inhibitor of MYC identified in a Kröhnke pyridine libraryJonathan R Hart, Amanda L Garner, Jing Yu, et al.Bioorganic & Medicinal Chemistry|July 25, 2018
Synthetic molecules for disruption of the MYC protein-protein interfaceNicholas T Jacob, Pedro O Miranda, Ryan J Shirey, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Cancer-specific mutations in PIK3CA are oncogenic in vivoAndreas G Bader, Sohye Kang, Peter K VogtPageof 11